CluenexGlobe Life GL
Globe Life scores average on business quality (6.0 of 10). Here is why, in plain words, and what our sealed record shows.
Why it matters
- What Globe Life does
Globe Life provides life and supplemental health insurance to middle-income households through direct-to-consumer and agency channels, generating steady underwriting income and policy fees.
- What it does best
Globe Life excels at generating superior returns on equity, posting a 20.3% ROE that outpaces peers like MetLife at 12.9% and Prudential at 12.2%. This efficiency stems from a low-cost distribution model and disciplined underwriting that bypasses traditional broker networks.
- The main risk
Regulatory and reputational scrutiny tied to past short-seller allegations creates persistent headline risk that can depress valuation multiples despite stable operating metrics.
Quality, check by check
Scored against its own industry, from company filings.
Operating margin stands at 26.6% with an ROE of 20.3%, showing solid capital efficiency. Profitability remains stable as underwriting discipline offsets sluggish revenue expansion.
A niche focus on middle-income families creates sticky customer relationships built on specialized agent networks, reflected in an operating margin of 26.6% that beats most insurance peers.
Revenue grew 3.7% to $6.2B, a slight tick up from past periods but still ranking in the bottom quartile of its sector at the 24th percentile for growth.
Total debt sits at $2.6B against an interest coverage ratio of 11.7x, meaning debt servicing is manageable. Free cash flow reached $1.2B, supporting steady capital returns.
Insiders
Executives and directors, from SEC Form 4 filings we read ourselves. Open market trades only; grants, option exercises and pre-planned sales left out.
5 sold $30.0M outside pre-planned sales.
Our sealed record on GL
Verdicts appear here 30 days after we publish them; members see today's. Each one is in the nightly ledger, fingerprinted the night it was made.
The first sealed verdicts appear here on Oct 11, 2026.
Questions
Globe Life scores average on the Cluenex quality check (6.0 of 10), measured against its own industry. Profitability is fair, moat fair, growth slow and financial health strong.
In the last 90 days of SEC Form 4 filings: 5 sold $30.0M outside pre-planned sales.
Oct 21, 2026, after the close.
See GL today
- Today's verdict on GL, and why
- Fair value with cautious, base and optimistic cases
- The exact price that would change the verdict
- Which stocks each signal names, the night it fires
Cite this page: Cluenex, “Globe Life (GL)”, https://cluenex.com/stocks/gl/, data as of Oct 10, 2026.